The Bedford, Mass.-based women’s health company said Casey agreed to resign at its request but did not elaborate on the reasons for the ouster.
Hologic has shuffled its executive deck since bringing former Stryker (NYSE:SYK) CEO Steve MacMillan into the corner office last year. In March, Hologic announced the retirement of CFO Glenn Muir, who also served as finance & administration executive vice president, assistant treasurer and assistant secretary. Muir was with Hologic since 1988 and became CFO in 1992.
Also in March, Hologic welcomed new COO Eric Compton, formerly worldwide president of ortho clinical diagnostics at Johnson & Johnson (NYSE:JNJ), and shifted some seats among its SVPs, moving David Harding from group senior vice president and general manager of women’s health to senior vice president of global strategy. The company also hired Claus Egstrand as its new senior vice president and international general manager.
In May, the company tapped another former J&J exec, naming Robert McMahon as CFO. And in September, Hologic ousted the president of its diagnostics division, Rohan Hastie.
Cheetah Medical taps MGH doc, GE CMO Hansell for chief physician
Cheetah Medical said it named Dr. Douglas Hansell of Mass. General Hospital – and the former chief medical officer for GE Healthcare (NYSE:GE) – to be its new chief physician executive, replacing Dr. William "Pepper" Denman.
Vision-Ease Lens names former CooperVision prez CEO
Vision-Ease Lens said it named former CooperVision (NYSE:COO) president John Weber as its new CEO, replacing Doug Hepper , who’s slated to become chairman after more than 12 years in the corner office.
Crane out, Stewart in as Mela Sciences CEO
Mela Sciences said it’s replacing CEO Rose Crane with Michael Stewart, the former CEO of Surgical Laser Technologies who served as COO at PhotoMedex after it acquired SLT in 2002.
RIP MDMA founding chairman Thompson
Thomas "Tommy" Thompson, the founding chairman and longtime board member of the Medical Device Manufacturers Assn., died this month at age 76. Thompson helped form MDMA in 1992 "with the belief that the innovative and entrepreneurial sector of the industry needed a strong and independent voice in the nation’s capital," according to a press release.